Astellas Pharma joined PPMD for a webinar on May 19, 2021 to provide an update on the company’s ASP0367 development program. Research & Clinical Trial Webinars,Webinars 3 years ago You may also like 59:29 FibroGen Update on Pamrevlumab & Enrolling Non-Ambulatory Study (October 2017) 7 years ago Research & Clinical Trial Webinars,Webinars 57:15 MoveDMD Trial Open-Label Extension Results (October 2017) 7 years ago Research & Clinical Trial Webinars,Webinars 1:01:20 Gene Therapy for Duchenne – PART 2: Nationwide Children’s Hospital (September 2017) 7 years ago Research & Clinical Trial Webinars,Webinars gene therapy 1:08:13 Gene Therapy for Duchenne (August 2017) 7 years ago Research & Clinical Trial Webinars,Webinars gene therapy 58:24 Nationwide Children’s Hospital Carrier Study (May 2017) 7 years ago Research & Clinical Trial Webinars,Webinars 59:04 Results from Phase I/II HOPE Clinical Trial of CAP-1002 (April 2017) 8 years ago Research & Clinical Trial Webinars,Webinars 45:19 Givinostat in Duchenne (April 2017) 8 years ago Research & Clinical Trial Webinars,Webinars 45:38 Akashi Provides Update on HT-100 (March 2017) 8 years ago Research & Clinical Trial Webinars,Webinars «1…1617181920…25»Page 18 of 25
by: Parent Project Muscular Dystrophy
